Tenet director plans $3.2M stock sale

A Tenet Healthcare director filed a Rule 144 notice for a potential sale of 12,010 common shares acquired via restricted stock vesting.

Available on EDGAR 09/14/2026 - 02:28 PM EDT Accepted by SEC EDGAR 09/14/2026 - 02:28 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

TENET HEALTHCARE CORP (THC) received a Rule 144 notice covering a proposed sale of up to 12,010 shares of common stock held for the account of director Kerrey J. Robert. The shares, acquired through restricted stock vesting in May 2019 and May 2020 as compensation, may be sold through Fidelity Brokerage Services LLC on the NYSE.

Key Figures

Shares to be sold: 12,010 shares Aggregate market value: $3,212,675.00 Shares outstanding: 80,519,000 shares +3 more

6 metrics

Shares to be sold 12,010 shares Maximum number of Tenet Healthcare common shares covered by the Rule 144 notice

Aggregate market value $3,212,675.00 Aggregate market value of the 12,010 shares proposed to be sold

Shares outstanding 80,519,000 shares Tenet Healthcare common shares outstanding as referenced in the Form 144

Shares from 2019 vesting 5,784 shares Restricted stock vested on May 13, 2019 classified as compensation

Shares from 2020 vesting 6,226 shares Restricted stock vested on May 5, 2020 classified as compensation

Planned sale date September 14, 2026 Approximate date of sale listed for the Rule 144 transaction

Key Terms

Rule 144, Restricted Stock Vesting, compensation, Aggregate Market Value

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Common | 05/13/2019 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

compensation financial

"5784 | 05/13/2019 | Compensation"

Aggregate Market Value financial

"Common | Fidelity Brokerage Services LLC ... | 3212675.00"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for TENET HEALTHCARE (THC)?

The filing reports a proposed sale of up to 12,010 shares of Tenet Healthcare common stock for the account of director Kerrey J. Robert under Rule 144, indicating potential secondary market sales by an affiliate, not an issuance of new shares by the company.

How many THC shares are covered by this Rule 144 notice?

The notice covers up to 12,010 shares of Tenet Healthcare common stock, corresponding to 5,784 shares acquired on May 13, 2019 and 6,226 shares acquired on May 5, 2020 through restricted stock vesting as compensation.

What is the approximate market value of the THC shares in this Form 144?

The filing lists an aggregate market value of $3,212,675.00 for the 12,010 shares of Tenet Healthcare common stock that may be sold through Fidelity Brokerage Services LLC on the NYSE, as of the planned sale date stated in the notice.

When may the Tenet Healthcare (THC) shares be sold under this Form 144?

The notice states an approximate sale date of September 14, 2026 for the potential sale of 12,010 shares of Tenet Healthcare common stock by Fidelity Brokerage Services LLC on the NYSE under Rule 144.

How many Tenet Healthcare (THC) shares are outstanding in this Form 144?

The Form 144 lists 80,519,000 shares of Tenet Healthcare common stock as outstanding. This figure provides context for the relative size of the proposed 12,010-share sale, which represents only a small fraction of the total outstanding shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001179100
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TENET HEALTHCARE CORP
SEC File Number	001-07293
Address of Issuer	14201 DALLAS PARKWAY DALLAS TEXAS 75254
Phone	469-893-2200
Name of Person for Whose Account the Securities are To Be Sold	KERREY J ROBERT
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	12010	3212675.00	80519000	09/14/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/13/2019	Restricted Stock Vesting	Issuer			5784	05/13/2019	Compensation
Common	05/05/2020	Restricted Stock Vesting	Issuer			6226	05/05/2020	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/14/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Joseph Kerrey
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)